Opens in a new tab

Continuous Glucose Monitoring: What Your Numbers Are Telling You

Smiling Man

By Jaiwant Rangi, MD

If you remember one thing from this article, remember this: a continuous glucose monitor turns your blood sugar from a once-a-year mystery into a daily conversation with your own body.

For decades, we judged diabetes largely by an A1C, a single number measured a few times a year. A1C is valuable, but it is an average, and averages hide almost everything interesting underneath.

Imagine being told that the average temperature this month was 70 degrees. That does not tell you whether every day was comfortable or whether temperatures swung between 40 and 100.

Blood sugar works the same way.

Two people can have exactly the same A1C while living through very different glucose patterns. One may remain relatively stable throughout the day. The other may experience repeated highs followed by dangerous lows.

A continuous glucose monitor, or CGM, reveals those patterns.

It is a small sensor generally worn on the arm or abdomen, depending on the device. It measures glucose in the fluid beneath the skin every few minutes, day and night, and sends the readings to a receiver, smartphone, smartwatch, or insulin pump.

Instead of a few isolated snapshots, you receive a moving picture of what your glucose is doing and what may be driving it.

Why This Is Such a Big Deal

An A1C can estimate your average glucose over approximately two to three months. It cannot tell you:

  • What that plate of Chinese food or bowl of pasta actually did to you
  • Whether your glucose is falling at 3 a.m. while you sleep
  • Why you wake up with a high reading despite going to bed in range
  • How a walk after dinner changes your glucose response
  • Whether exercise raises or lowers your glucose
  • How stress, illness, travel, or poor sleep affects you
  • Why one supposedly “healthy” food spikes you while another does not
  • How often your glucose is fluctuating dramatically

A traditional finger-stick glucose meter provides one reading from one moment. It is useful, but it tells you what happened only when you chose to check.

A CGM fills in the hours between those checks.

Patients tell me the same thing repeatedly: for the first time, they can see the consequences of a choice and see the reward of a better one.

One patient described learning that a very high glucose spike could disrupt his control far beyond the meal itself. Once he saw the pattern, he began making different choices.

No one needed to lecture him. The data taught him.

That is learning, not willpower.

A1C Still Matters but It Is Not the Whole Story

A1C remains an important biomarker. It is associated with the risk of diabetes complications and helps clinicians assess longer-term glucose management.

But A1C has limitations.

Because it is an average, it can hide:

  • Severe glucose variability
  • Frequent hypoglycemia
  • Overnight highs or lows
  • Post-meal spikes
  • Differences between weekday and weekend habits
  • Changes that occurred only recently

A1C can also be affected by conditions that alter red blood cells, including certain types of anemia, kidney disease, blood loss, transfusion, pregnancy, and some hemoglobin variants.

A CGM does not replace every laboratory test. It gives us a different kind of information: what glucose is doing in real life.

The American Diabetes Association recognizes CGM as an important tool for evaluating individual responses to treatment and lifestyle changes.

The most useful approach is often to examine A1C and CGM data together.

The Numbers That Matter

A CGM produces thousands of readings, but you do not need to analyze every number. Several summary measurements can tell us most of what we need to know.

Time in Range

Time in range is the percentage of time your glucose stays within your target zone.

For many nonpregnant adults with diabetes, the standard range is 70 to 180 mg/dL, with a general goal of spending more than 70% of the day in that range. That equals approximately 16 hours and 48 minutes each day.

But targets must be individualized.

Older adults, people with frailty, those with a high risk of severe hypoglycemia, and people with certain medical conditions may need safer, less aggressive targets. The 2026 ADA Standards, for example, use a time-in-range goal above 50% for some older adults with complex health needs.

Pregnancy also requires different glucose targets.

Time in range translates diabetes management into something tangible. Instead of waiting three months to see whether A1C changed, you can watch your time in range improve this week.

Time Below Range

Time below range shows how frequently glucose is too low.

For many adults, the general goal is:

  • Less than 4% of readings below 70 mg/dL
  • Less than 1% below 54 mg/dL

Those percentages represent less than approximately one hour per day below 70 and less than 15 minutes per day below 54.

Hypoglycemia can cause shakiness, sweating, hunger, confusion, weakness, seizures, loss of consciousness, and in severe circumstances, death.

That is why a “good” average glucose is not truly good if it is being achieved through frequent lows.

Safety comes before perfection.

Time Above Range

Time above range reveals how much of the day glucose remains elevated.

Repeated or prolonged elevations can identify:

  • Meals that need adjustment
  • Insufficient medication coverage
  • Missed or delayed insulin
  • Dawn phenomenon
  • Illness or stress
  • Problems with an insulin pump or infusion site
  • A treatment plan that is no longer adequate

The goal is not to panic every time glucose briefly rises. Glucose normally changes after eating.

We are looking for the height, duration, frequency, and consistency of those elevations.

Glucose Management Indicator

The glucose management indicator, or GMI, estimates what your A1C might be based on recent CGM readings.

GMI and laboratory A1C are not always identical and they do not need to be. When they differ significantly, that difference can become useful clinical information.

For example, it may suggest that recent control has changed or that a medical condition is affecting the reliability of the laboratory A1C.

Glucose Variability

Variability describes how much glucose rises and falls.

A graph that resembles a roller coaster can be physically and emotionally exhausting, even when the overall average appears acceptable. Large swings may also increase the risk of hypoglycemia, especially for people taking insulin or certain diabetes medications.

Sometimes the first goal is not to lower the average dramatically. It is to make the line steadier and safer.

Who Benefits From a CGM?

People Using Insulin

CGM is especially important for people with type 1 diabetes and for anyone using insulin.

It can:

  • Warn of an impending low
  • Show whether glucose is rising or falling
  • Help guide mealtime and correction decisions
  • Reveal overnight patterns
  • Reduce the burden of frequent finger sticks
  • Improve time in range
  • Help clinicians adjust insulin more safely

Trend arrows are particularly useful. A reading of 100 mg/dL with a horizontal arrow is very different from a reading of 100 with two downward arrows.

The number tells you where you are. The arrow tells you where you may be going.

People Using Automated Insulin Delivery

Modern insulin pumps can communicate directly with a CGM.

These automated insulin-delivery systems use sensor information to adjust insulin throughout the day and night. Depending on the system, they may reduce or pause insulin when glucose is predicted to fall and increase delivery when glucose is rising.

They are not fully automatic replacements for diabetes self-management, but they provide an extraordinary safety and treatment tool.

People With Type 2 Diabetes Not Using Insulin

Evidence is growing for CGM use in people with type 2 diabetes who do not use insulin.

A 2025 systematic review and meta-analysis found that CGM use in adults with non-insulin-treated type 2 diabetes was associated with improvements in glucose outcomes and patient experience.

Some people may benefit from continuous use. Others may obtain meaningful information by wearing a CGM periodically for example, for two weeks every few months to identify patterns and guide treatment.

Access and insurance coverage remain variable.

People With Prediabetes

For someone with prediabetes, a short period of CGM use may reveal how meals, activity, sleep, and stress affect glucose.

That can be educational and motivating, but the data must be interpreted carefully. We do not yet have universally accepted CGM treatment targets for people with prediabetes, and diagnosis should still be based on validated laboratory criteria, not a few sensor spikes.

People Without Diabetes

Many people without diabetes are curious about CGM technology.

A brief, structured experiment may offer insight, particularly when guided by a knowledgeable clinician. But routine CGM use in people without diabetes is not yet supported by the same level of evidence as its use in diabetes.

More data are not automatically better.

For some people, constant glucose visibility can create anxiety, unnecessary food restriction, or fear of normal post-meal changes. The objective should be better health, not a perfectly flat line.

How to Use a CGM Well, Without Becoming Obsessed

A CGM should be a coach, not a judge.

Look for Patterns, Not Isolated Readings

One unusual reading may mean very little. A repeated response occurring at the same time or after the same meal is much more useful.

Ask:

  • Does this happen repeatedly?
  • What occurred before it?
  • How long did it last?
  • What changed it?
  • Is it clinically important?

Run Simple Experiments

CGM becomes powerful when you change one variable at a time.

Try:

  • Eating the same meal with and without a 10-minute walk afterward
  • Eating vegetables and protein before the carbohydrate portion
  • Comparing an earlier dinner with a late-night meal
  • Comparing a well-rested day with a sleep-deprived day
  • Changing the portion rather than eliminating the food
  • Pairing carbohydrates with protein and fiber

The goal is not to discover one “perfect” food. It is to learn what produces a more manageable response in your body.

Do Not Chase Every Spike

Glucose is supposed to rise after eating. A temporary increase is not a moral failure.

Do not begin stacking extra insulin, overexercising, skipping meals, or unnecessarily restricting nutritious foods in pursuit of a perfectly flat graph.

If you use insulin, avoid making major dosing changes without proper guidance. Reacting too aggressively to a rising sensor reading can cause delayed hypoglycemia.

Use Enough Data

A single day rarely represents your usual life.

Clinicians commonly review approximately 14 days of CGM data, assuming the sensor was active enough to provide a representative picture. We look for recurring patterns rather than treating every day as identical.

Bring the Report to Your Visits

Ask your clinician to review your ambulatory glucose profile, or AGP.

This standardized report summarizes:

  • Average glucose
  • GMI
  • Time in range
  • Time above and below range
  • Glucose variability
  • Daily patterns

Two weeks of CGM data may reveal more actionable information than a three-month average alone.

Know the Limitations

CGMs are highly useful, but they are not perfect.

The sensor measures glucose in interstitial fluid rather than directly in the bloodstream. When glucose is changing rapidly, the sensor may lag slightly behind a finger-stick blood glucose reading.

Pressure on the sensor during sleep can sometimes produce a falsely low reading, often called a compression low.

Readings may also be less reliable during the sensor’s warm-up period or if the sensor becomes loose or damaged.

If your symptoms do not match the reading, especially if the CGM reports a low but you feel completely normal, follow the device instructions. A finger-stick confirmation may be appropriate before making a treatment decision.

Never ignore significant symptoms simply because a device displays a reassuring number.

The Bigger Picture

Seeing glucose in real time is one of the most motivating advances in modern metabolic care.

It changes the conversation from:

“Your A1C is high. Try harder.”

to:

“Here is where your glucose rises. Here is when it falls. Here is what improves it. Now we can build a better plan.”

That shift matters.

CGM transforms abstract health advice into personal evidence. It helps people understand that food, movement, stress, sleep, medication, and timing do not operate independently. They create patterns.

This fits directly into my Lower The Dose® approach:

  • Measure clearly
  • Identify the pattern
  • Act daily
  • Adjust intelligently
  • Use technology when your biology calls for it
  • Reach your goals with the lowest effective treatment burden

A CGM cannot make decisions for you. It cannot replace medical judgment, nutrition, movement, sleep, or appropriate medication.

But it can make the invisible visible.

And sometimes the most powerful step in changing your health is simply being able to see what is happening.

Ask your clinician whether continuous, periodic, or professional CGM use is appropriate for you.

Stop guessing. Start learning from your own patterns.

This article provides general health information and is not a substitute for medical advice, diagnosis, or an individualized treatment plan developed with your own clinician. CGM readings and targets should be interpreted in the context of your medications, health conditions, and personal treatment goals.

Want the full picture, not just your blood sugar? Take the Longevity Quiz at rangimd.com/quiz.

Dr. Rangi
Dr. Jaiwant Rangi, MD is a board-certified endocrinologist and inspirational speaker who blends science with soul. With over 25 years of experience in hormone and metabolic health, she weaves mindfulness and integrative healing into her message of transformation. Through her own journey of loss and renewal, Dr. Rangi inspires others to heal from burnout, reclaim their vitality, and step into a life of purpose and balance.
Smiling Man

By Jaiwant Rangi, MD

If you remember one thing from this article, remember this: a continuous glucose monitor turns your blood sugar from a once-a-year mystery into a daily conversation with your own body.

For decades, we judged diabetes largely by an A1C, a single number measured a few times a year. A1C is valuable, but it is an average, and averages hide almost everything interesting underneath.

Imagine being told that the average temperature this month was 70 degrees. That does not tell you whether every day was comfortable or whether temperatures swung between 40 and 100.

Blood sugar works the same way.

Two people can have exactly the same A1C while living through very different glucose patterns. One may remain relatively stable throughout the day. The other may experience repeated highs followed by dangerous lows.

A continuous glucose monitor, or CGM, reveals those patterns.

It is a small sensor generally worn on the arm or abdomen, depending on the device. It measures glucose in the fluid beneath the skin every few minutes, day and night, and sends the readings to a receiver, smartphone, smartwatch, or insulin pump.

Instead of a few isolated snapshots, you receive a moving picture of what your glucose is doing and what may be driving it.

Why This Is Such a Big Deal

An A1C can estimate your average glucose over approximately two to three months. It cannot tell you:

  • What that plate of Chinese food or bowl of pasta actually did to you
  • Whether your glucose is falling at 3 a.m. while you sleep
  • Why you wake up with a high reading despite going to bed in range
  • How a walk after dinner changes your glucose response
  • Whether exercise raises or lowers your glucose
  • How stress, illness, travel, or poor sleep affects you
  • Why one supposedly “healthy” food spikes you while another does not
  • How often your glucose is fluctuating dramatically

A traditional finger-stick glucose meter provides one reading from one moment. It is useful, but it tells you what happened only when you chose to check.

A CGM fills in the hours between those checks.

Patients tell me the same thing repeatedly: for the first time, they can see the consequences of a choice and see the reward of a better one.

One patient described learning that a very high glucose spike could disrupt his control far beyond the meal itself. Once he saw the pattern, he began making different choices.

No one needed to lecture him. The data taught him.

That is learning, not willpower.

A1C Still Matters but It Is Not the Whole Story

A1C remains an important biomarker. It is associated with the risk of diabetes complications and helps clinicians assess longer-term glucose management.

But A1C has limitations.

Because it is an average, it can hide:

  • Severe glucose variability
  • Frequent hypoglycemia
  • Overnight highs or lows
  • Post-meal spikes
  • Differences between weekday and weekend habits
  • Changes that occurred only recently

A1C can also be affected by conditions that alter red blood cells, including certain types of anemia, kidney disease, blood loss, transfusion, pregnancy, and some hemoglobin variants.

A CGM does not replace every laboratory test. It gives us a different kind of information: what glucose is doing in real life.

The American Diabetes Association recognizes CGM as an important tool for evaluating individual responses to treatment and lifestyle changes.

The most useful approach is often to examine A1C and CGM data together.

The Numbers That Matter

A CGM produces thousands of readings, but you do not need to analyze every number. Several summary measurements can tell us most of what we need to know.

Time in Range

Time in range is the percentage of time your glucose stays within your target zone.

For many nonpregnant adults with diabetes, the standard range is 70 to 180 mg/dL, with a general goal of spending more than 70% of the day in that range. That equals approximately 16 hours and 48 minutes each day.

But targets must be individualized.

Older adults, people with frailty, those with a high risk of severe hypoglycemia, and people with certain medical conditions may need safer, less aggressive targets. The 2026 ADA Standards, for example, use a time-in-range goal above 50% for some older adults with complex health needs.

Pregnancy also requires different glucose targets.

Time in range translates diabetes management into something tangible. Instead of waiting three months to see whether A1C changed, you can watch your time in range improve this week.

Time Below Range

Time below range shows how frequently glucose is too low.

For many adults, the general goal is:

  • Less than 4% of readings below 70 mg/dL
  • Less than 1% below 54 mg/dL

Those percentages represent less than approximately one hour per day below 70 and less than 15 minutes per day below 54.

Hypoglycemia can cause shakiness, sweating, hunger, confusion, weakness, seizures, loss of consciousness, and in severe circumstances, death.

That is why a “good” average glucose is not truly good if it is being achieved through frequent lows.

Safety comes before perfection.

Time Above Range

Time above range reveals how much of the day glucose remains elevated.

Repeated or prolonged elevations can identify:

  • Meals that need adjustment
  • Insufficient medication coverage
  • Missed or delayed insulin
  • Dawn phenomenon
  • Illness or stress
  • Problems with an insulin pump or infusion site
  • A treatment plan that is no longer adequate

The goal is not to panic every time glucose briefly rises. Glucose normally changes after eating.

We are looking for the height, duration, frequency, and consistency of those elevations.

Glucose Management Indicator

The glucose management indicator, or GMI, estimates what your A1C might be based on recent CGM readings.

GMI and laboratory A1C are not always identical and they do not need to be. When they differ significantly, that difference can become useful clinical information.

For example, it may suggest that recent control has changed or that a medical condition is affecting the reliability of the laboratory A1C.

Glucose Variability

Variability describes how much glucose rises and falls.

A graph that resembles a roller coaster can be physically and emotionally exhausting, even when the overall average appears acceptable. Large swings may also increase the risk of hypoglycemia, especially for people taking insulin or certain diabetes medications.

Sometimes the first goal is not to lower the average dramatically. It is to make the line steadier and safer.

Who Benefits From a CGM?

People Using Insulin

CGM is especially important for people with type 1 diabetes and for anyone using insulin.

It can:

  • Warn of an impending low
  • Show whether glucose is rising or falling
  • Help guide mealtime and correction decisions
  • Reveal overnight patterns
  • Reduce the burden of frequent finger sticks
  • Improve time in range
  • Help clinicians adjust insulin more safely

Trend arrows are particularly useful. A reading of 100 mg/dL with a horizontal arrow is very different from a reading of 100 with two downward arrows.

The number tells you where you are. The arrow tells you where you may be going.

People Using Automated Insulin Delivery

Modern insulin pumps can communicate directly with a CGM.

These automated insulin-delivery systems use sensor information to adjust insulin throughout the day and night. Depending on the system, they may reduce or pause insulin when glucose is predicted to fall and increase delivery when glucose is rising.

They are not fully automatic replacements for diabetes self-management, but they provide an extraordinary safety and treatment tool.

People With Type 2 Diabetes Not Using Insulin

Evidence is growing for CGM use in people with type 2 diabetes who do not use insulin.

A 2025 systematic review and meta-analysis found that CGM use in adults with non-insulin-treated type 2 diabetes was associated with improvements in glucose outcomes and patient experience.

Some people may benefit from continuous use. Others may obtain meaningful information by wearing a CGM periodically for example, for two weeks every few months to identify patterns and guide treatment.

Access and insurance coverage remain variable.

People With Prediabetes

For someone with prediabetes, a short period of CGM use may reveal how meals, activity, sleep, and stress affect glucose.

That can be educational and motivating, but the data must be interpreted carefully. We do not yet have universally accepted CGM treatment targets for people with prediabetes, and diagnosis should still be based on validated laboratory criteria, not a few sensor spikes.

People Without Diabetes

Many people without diabetes are curious about CGM technology.

A brief, structured experiment may offer insight, particularly when guided by a knowledgeable clinician. But routine CGM use in people without diabetes is not yet supported by the same level of evidence as its use in diabetes.

More data are not automatically better.

For some people, constant glucose visibility can create anxiety, unnecessary food restriction, or fear of normal post-meal changes. The objective should be better health, not a perfectly flat line.

How to Use a CGM Well, Without Becoming Obsessed

A CGM should be a coach, not a judge.

Look for Patterns, Not Isolated Readings

One unusual reading may mean very little. A repeated response occurring at the same time or after the same meal is much more useful.

Ask:

  • Does this happen repeatedly?
  • What occurred before it?
  • How long did it last?
  • What changed it?
  • Is it clinically important?

Run Simple Experiments

CGM becomes powerful when you change one variable at a time.

Try:

  • Eating the same meal with and without a 10-minute walk afterward
  • Eating vegetables and protein before the carbohydrate portion
  • Comparing an earlier dinner with a late-night meal
  • Comparing a well-rested day with a sleep-deprived day
  • Changing the portion rather than eliminating the food
  • Pairing carbohydrates with protein and fiber

The goal is not to discover one “perfect” food. It is to learn what produces a more manageable response in your body.

Do Not Chase Every Spike

Glucose is supposed to rise after eating. A temporary increase is not a moral failure.

Do not begin stacking extra insulin, overexercising, skipping meals, or unnecessarily restricting nutritious foods in pursuit of a perfectly flat graph.

If you use insulin, avoid making major dosing changes without proper guidance. Reacting too aggressively to a rising sensor reading can cause delayed hypoglycemia.

Use Enough Data

A single day rarely represents your usual life.

Clinicians commonly review approximately 14 days of CGM data, assuming the sensor was active enough to provide a representative picture. We look for recurring patterns rather than treating every day as identical.

Bring the Report to Your Visits

Ask your clinician to review your ambulatory glucose profile, or AGP.

This standardized report summarizes:

  • Average glucose
  • GMI
  • Time in range
  • Time above and below range
  • Glucose variability
  • Daily patterns

Two weeks of CGM data may reveal more actionable information than a three-month average alone.

Know the Limitations

CGMs are highly useful, but they are not perfect.

The sensor measures glucose in interstitial fluid rather than directly in the bloodstream. When glucose is changing rapidly, the sensor may lag slightly behind a finger-stick blood glucose reading.

Pressure on the sensor during sleep can sometimes produce a falsely low reading, often called a compression low.

Readings may also be less reliable during the sensor’s warm-up period or if the sensor becomes loose or damaged.

If your symptoms do not match the reading, especially if the CGM reports a low but you feel completely normal, follow the device instructions. A finger-stick confirmation may be appropriate before making a treatment decision.

Never ignore significant symptoms simply because a device displays a reassuring number.

The Bigger Picture

Seeing glucose in real time is one of the most motivating advances in modern metabolic care.

It changes the conversation from:

“Your A1C is high. Try harder.”

to:

“Here is where your glucose rises. Here is when it falls. Here is what improves it. Now we can build a better plan.”

That shift matters.

CGM transforms abstract health advice into personal evidence. It helps people understand that food, movement, stress, sleep, medication, and timing do not operate independently. They create patterns.

This fits directly into my Lower The Dose® approach:

  • Measure clearly
  • Identify the pattern
  • Act daily
  • Adjust intelligently
  • Use technology when your biology calls for it
  • Reach your goals with the lowest effective treatment burden

A CGM cannot make decisions for you. It cannot replace medical judgment, nutrition, movement, sleep, or appropriate medication.

But it can make the invisible visible.

And sometimes the most powerful step in changing your health is simply being able to see what is happening.

Ask your clinician whether continuous, periodic, or professional CGM use is appropriate for you.

Stop guessing. Start learning from your own patterns.

This article provides general health information and is not a substitute for medical advice, diagnosis, or an individualized treatment plan developed with your own clinician. CGM readings and targets should be interpreted in the context of your medications, health conditions, and personal treatment goals.

Want the full picture, not just your blood sugar? Take the Longevity Quiz at rangimd.com/quiz.

Dr. Rangi is a dual board-certified psychiatrist and addiction medicine specialist dedicated to transforming lives through innovative, upstream approaches to mental health and substance use care. As a sought-after speaker and thought leader, she combines clinical expertise with a compassionate vision to empower individuals and communities toward lasting wellness.

[addtoany]
Tags: